Mutation of the gene encoding the ROR2 tyrosine kinase causes autosomal recessive Robinow syndrome

被引:211
作者
van Bokhoven, H
Celli, J
Kayserili, H
van Beusekom, E
Balci, S
Brussel, W
Skovby, F
Kerr, B
Percin, EF
Akarsu, N
Brunner, HG [1 ]
机构
[1] Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands
[2] Istanbul Univ, Istanbul Fac Med, Div Med Genet, Dept Pediat, Istanbul, Turkey
[3] Hacettepe Univ, Inst Child Hlth, Div Clin Genet, Ankara, Turkey
[4] Rijnstate Hosp, Dept Pediat, Arnhem, Netherlands
[5] Rigshosp, Dept Clin Genet, Copenhagen, Denmark
[6] Royal Manchester Childrens Hosp, Reg Genet Serv, Manchester, Lancs, England
[7] Cumhuriye Univ, Dept Med Biol & Genet, Sivas, Turkey
关键词
D O I
10.1038/78113
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Robinow syndrome is a short-limbed dwarfism characterized by abnormal morphogenesis of the face and external genitalia, and vertebral segmentation(1,2). The recessive form of Robinow syndrome (RRS; OMIM 268310). particularly frequent in Turkey(3-6), has a high incidence of abnormalities of the vertebral column such as hemivertebrae and rib fusions. which is not seen in the dominant form. Some patients have cardiac malformations or facial clefting. We have mapped a gene for RRS to 9q21-q23 in 11 families. Haplotype sharing was observed between three families from Turkey, which localized the gene to a 4.9-cM interval. The gene ROR2, which encodes an orphan membrane-bound tyrosine kinase, maps to this region. Heterozygous (presumed gain of function) mutations in ROR2 were previously shown to cause dominant brachydactyly type B (BDB; ref. 7). In contrast, Ror2(-/-) mice have a short-limbed phenotype that is more reminiscent of the mesomelic shortening observed in RRS. We detected several homozygous ROR2 mutations in our cohort of RRS patients that are located upstream from those previously found in BDB. The ROR2 mutations present in RRS result in premature stop codons and predict nonfunctional proteins.
引用
收藏
页码:423 / 426
页数:4
相关论文
共 31 条
[1]  
Aksit S, 1997, CLIN GENET, V52, P226
[2]  
Atalay S, 1993, Clin Dysmorphol, V2, P208
[3]  
Balci S, 1993, Clin Dysmorphol, V2, P199
[4]  
Balci S, 1998, AM J MED GENET, V79, P27, DOI 10.1002/(SICI)1096-8628(19980827)79:1<27::AID-AJMG7>3.0.CO
[5]  
2-F
[6]   Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes [J].
Bellus, GA ;
Gaudenz, K ;
Zackai, EH ;
Clarke, LA ;
Szabo, J ;
Francomano, CA ;
Muenke, M .
NATURE GENETICS, 1996, 14 (02) :174-176
[7]  
BUTLER MG, 1987, CLIN GENET, V31, P77
[8]  
Cunningham ME, 1997, J BIOL CHEM, V272, P10957
[9]   Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development [J].
DeChiara, TM ;
Kimble, RB ;
Poueymirou, WT ;
Rojas, J ;
Masiakowski, P ;
Valenzuela, DM ;
Yancopoulos, GD .
NATURE GENETICS, 2000, 24 (03) :271-274
[10]   Fibroblast growth factor receptor 3 is a negative regulator of bone growth [J].
Deng, CX ;
WynshawBoris, A ;
Zhou, F ;
Kuo, A ;
Leder, P .
CELL, 1996, 84 (06) :911-921